Statins and prostate cancer—hype or hope? The epidemiological perspective

BACKGROUND: Men using cholesterol-lowering statin medications have been found to have lower risks of both advanced and fatal prostate cancer in multiple registry-based studies and prospective cohort studies. Statin use has also been associated with longer survival among men already diagnosed with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Craig, Emma L., Stopsack, Konrad H., Evergren, Emma, Penn, Linda Z., Freedland, Stephen J., Hamilton, Robert J., Allott, Emma H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705231/
https://www.ncbi.nlm.nih.gov/pubmed/35732821
http://dx.doi.org/10.1038/s41391-022-00554-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705231/
https://www.ncbi.nlm.nih.gov/pubmed/35732821
http://dx.doi.org/10.1038/s41391-022-00554-1

Ejemplares similares